General Information
3-V Bio NASH 005
A Phase 2, Multi‐center, Single‐blind, Randomized, Placebo Controlled Study of TVB‐2640 in Subjects with Non‐alcoholic Steatohepatitis
| Protocol | 3V2640-CLIN-005 |
|---|---|
| Identifier | |
| UID | 3162374a-8a27-43f3-b0eb-960c707f7861 |
| Status | Done - Archived |
| Phase | 2 |
| Category | NASH / Adult |
| Launch Year | 2019 |
| NCT Number | - |
| Created | 2019-02-27 12:03 |
| Last Updated | 2019-02-27 12:03 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2020-02-05 | No |
| Enrollment Open | 2019-03-27 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2019-03-15 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2020-09-18 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Mohseni, Rizwana | RMohseni | No |
| Recruiter | - | No | |
| Coordinator | Diaz-Chavez, Mayra | MDiaz-Chavez | No |
| Regulatory | Perez, Myrna | MPerez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | 3-V Biosciences, Inc. |
|---|---|
| Division | 3-VBio |
| Team | 3-VBio |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | ProSciento, Inc. |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
